Center for Genomic Medicine, Rigshospitalet, Copenhagen, Denmark.
Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Microb Genom. 2021 Jul;7(7). doi: 10.1099/mgen.0.000582.
spp. are emerging pathogens in patients with cystic fibrosis (CF) and spp. caused infections are associated with more severe disease outcomes and high intrinsic antibiotic resistance. While conventional CF pathogens are studied extensively, little is known about the genetic determinants leading to antibiotic resistance and the genetic adaptation in spp. infections. Here, we analysed 101 spp. genomes from 51 patients with CF isolated during the course of up to 20 years of infection to identify within-host adaptation, mutational signatures and genetic variation associated with increased antibiotic resistance. We found that the same regulatory and inorganic ion transport genes were frequently mutated in persisting clone types within and between species, indicating convergent genetic adaptation. Genome-wide association study of six antibiotic resistance phenotypes revealed the enrichment of associated genes involved in inorganic ion transport, transcription gene enrichment in β-lactams, and energy production and translation gene enrichment in the trimethoprim/sulfonamide group. Overall, we provide insights into the pathogenomics of spp. infections in patients with CF airways. Since emerging pathogens are increasingly recognized as an important healthcare issue, our findings on evolution of antibiotic resistance and genetic adaptation can facilitate better understanding of disease progression and how mutational changes have implications for patients with CF.
种是囊性纤维化(CF)患者中新兴的病原体,种引起的感染与更严重的疾病结果和高固有抗生素耐药性相关。虽然传统的 CF 病原体被广泛研究,但对于导致抗生素耐药性的遗传决定因素以及种感染中的遗传适应性知之甚少。在这里,我们分析了 51 名 CF 患者在长达 20 年的感染过程中分离出的 101 种基因组,以确定与抗生素耐药性增加相关的宿主内适应性、突变特征和遗传变异。我们发现,在同种和种间持续存在的克隆类型中,相同的调节和无机离子转运基因经常发生突变,表明存在趋同的遗传适应性。对六种抗生素耐药表型的全基因组关联研究揭示了与无机离子转运相关的相关基因富集、β-内酰胺转录基因富集以及三嗪/磺胺类药物组中能量产生和翻译基因富集。总的来说,我们提供了对 CF 气道患者种感染的病原体组学的见解。由于新兴病原体越来越被认为是一个重要的医疗保健问题,我们关于抗生素耐药性和遗传适应性进化的发现可以帮助更好地了解疾病进展以及突变变化对 CF 患者的影响。